Connection

Perry Molinoff to Pindolol

Back to Details
This is a "connection" page, showing publications Perry Molinoff has written about Pindolol.
Perry Molinoff
Connection Strength
0.888
Pindolol
  1. Down-regulation of beta-adrenergic receptors by pindolol in Gs alpha-transfected S49 cyc- murine lymphoma cells. J Neurochem. 1992 Mar; 58(3):1093-1103.
    View in: PubMed
    Score: 0.099
  2. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther. 1986 Oct; 239(1):117-23.
    View in: PubMed
    Score: 0.068
  3. Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Jul; 238(1):46-53.
    View in: PubMed
    Score: 0.067
  4. Effects of pindolol and propranolol on beta-adrenergic receptors on human lymphocytes. Br J Clin Pharmacol. 1982; 13(Suppl 2):365S.
    View in: PubMed
    Score: 0.049
  5. Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex. Brain Res. 1980 Apr 28; 188(2):357-68.
    View in: PubMed
    Score: 0.044
  6. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists. Mol Pharmacol. 1992 Sep; 42(3):464-70.
    View in: PubMed
    Score: 0.026
  7. Subtype-selective immunoprecipitation of the beta 2-adrenergic receptor. J Neurochem. 1989 Aug; 53(2):362-9.
    View in: PubMed
    Score: 0.021
  8. Effect of exercise duration on density and coupling of beta-adrenergic receptors on human mononuclear cells. J Appl Physiol (1985). 1989 Mar; 66(3):1494-500.
    View in: PubMed
    Score: 0.020
  9. Interaction of beta-adrenergic receptors with the inhibitory guanine nucleotide-binding protein of adenylate cyclase in membranes prepared from cyc- S49 lymphoma cells. Biochem Pharmacol. 1988 Nov 15; 37(22):4289-97.
    View in: PubMed
    Score: 0.020
  10. Interactions of beta-adrenergic receptors with a membrane protein other than the stimulatory guanine nucleotide-binding protein. Biochem Pharmacol. 1987 Jul 15; 36(14):2263-9.
    View in: PubMed
    Score: 0.018
  11. Distribution and properties of beta-adrenergic receptors in human iris-ciliary body. Invest Ophthalmol Vis Sci. 1987 Mar; 28(3):420-30.
    View in: PubMed
    Score: 0.017
  12. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists. J Pharmacol Exp Ther. 1986 Dec; 239(3):654-60.
    View in: PubMed
    Score: 0.017
  13. Kinetic analysis of the interactions of agonists and antagonists with beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Oct; 239(1):136-43.
    View in: PubMed
    Score: 0.017
  14. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.017
  15. Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase. J Pharmacol Exp Ther. 1986 Sep; 238(3):886-92.
    View in: PubMed
    Score: 0.017
  16. Turnover of beta 1- and beta 2-adrenergic receptors after down-regulation or irreversible blockade. Mol Pharmacol. 1986 Aug; 30(2):104-11.
    View in: PubMed
    Score: 0.017
  17. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors. Am J Cardiol. 1986 Apr 25; 57(12):17F-22F.
    View in: PubMed
    Score: 0.016
  18. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):154-64.
    View in: PubMed
    Score: 0.016
  19. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors. J Pharmacol Exp Ther. 1986 Apr; 237(1):165-72.
    View in: PubMed
    Score: 0.016
  20. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists. J Pharmacol Exp Ther. 1985 Dec; 235(3):657-64.
    View in: PubMed
    Score: 0.016
  21. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep; 234(3):561-8.
    View in: PubMed
    Score: 0.016
  22. Beta 2-adrenergic receptors contribute to catecholamine-stimulated shortening of action potential duration in dog atrial muscle. Proc Natl Acad Sci U S A. 1985 Jul; 82(13):4521-5.
    View in: PubMed
    Score: 0.016
  23. Interactions of agonists with beta-adrenergic receptors on S49 lymphoma cells. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:13-27.
    View in: PubMed
    Score: 0.015
  24. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
    View in: PubMed
    Score: 0.014
  25. Alpha- and beta-adrenergic receptor subtypes properties, distribution and regulation. Drugs. 1984; 28 Suppl 2:1-15.
    View in: PubMed
    Score: 0.014
  26. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Mol Pharmacol. 1983 Nov; 24(3):398-408.
    View in: PubMed
    Score: 0.014
  27. Effects of drugs on beta-adrenergic receptors on human lymphocytes. J Cardiovasc Pharmacol. 1983; 5 Suppl 1:S63-7.
    View in: PubMed
    Score: 0.013
  28. Selective changes in the density of beta 1-adrenergic receptors in rat striatum following chronic drug treatment and adrenalectomy. Brain Res. 1982 Dec 09; 252(2):309-14.
    View in: PubMed
    Score: 0.013
  29. Selective increases in the density of cerebellar beta-1-adrenergic receptors. Brain Res. 1982 Feb 25; 234(2):474-9.
    View in: PubMed
    Score: 0.012
  30. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981 Jul 27; 29(4):313-30.
    View in: PubMed
    Score: 0.012
  31. Interactions of agonists and antagonists with beta-adrenergic receptors. Adv Cyclic Nucleotide Res. 1981; 14:51-67.
    View in: PubMed
    Score: 0.011
  32. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors. Mol Pharmacol. 1980 Nov; 18(3):341-7.
    View in: PubMed
    Score: 0.011
  33. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest. 1980 May; 65(5):949-57.
    View in: PubMed
    Score: 0.011
  34. Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart. J Pharmacol Exp Ther. 1980 Mar; 212(3):503-8.
    View in: PubMed
    Score: 0.011
  35. A comparison of the beta-adrenergic receptor of the turkey erythrocyte with mammalian beta1 and beta2 receptors. Mol Pharmacol. 1980 Jan; 17(1):1-7.
    View in: PubMed
    Score: 0.011
  36. Interactions of agonists and antagonists with beta-adrenergic receptors on intact L6 muscle cells. J Cyclic Nucleotide Res. 1980; 6(6):421-35.
    View in: PubMed
    Score: 0.011
  37. Comparison of beta adrenergic receptor subtypes in mammalian tissues. J Pharmacol Exp Ther. 1979 Dec; 211(3):502-8.
    View in: PubMed
    Score: 0.011
  38. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain. J Pharmacol Exp Ther. 1979 Aug; 210(2):215-21.
    View in: PubMed
    Score: 0.010
  39. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro. Mol Pharmacol. 1979 Jul; 16(1):21-33.
    View in: PubMed
    Score: 0.010
  40. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul; 16(1):34-46.
    View in: PubMed
    Score: 0.010
  41. Regulation of beta-adrenergic receptors in the cerebral cortex. Adv Cyclic Nucleotide Res. 1978; 9:465-83.
    View in: PubMed
    Score: 0.009
  42. Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses. Mol Pharmacol. 1977 Nov; 13(6):1170-80.
    View in: PubMed
    Score: 0.009
  43. Effects of 6-hydroxydopamine on the development of the beta adrenergic receptor/adenylate cyclase system in rat cerebral cortex. J Pharmacol Exp Ther. 1977 Oct; 203(1):132-43.
    View in: PubMed
    Score: 0.009
  44. Characterization of a mouse beta 1-adrenergic receptor genomic clone. DNA Cell Biol. 1993 Jul-Aug; 12(6):537-47.
    View in: PubMed
    Score: 0.007
  45. Characterization of beta-adrenergic receptors in cultured human trabecular cells and in human trabecular meshwork. Invest Ophthalmol Vis Sci. 1989 Jan; 30(1):51-7.
    View in: PubMed
    Score: 0.005
  46. Genetic influence on the regulation of beta adrenergic receptors in mice. J Pharmacol Exp Ther. 1986 Jan; 236(1):24-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.